Cardiac Structure and Function in MPS
Key facts
- Who runs it
- Children's Hospital of Orange County
- Where
- Minneapolis, Orange, and St Louis, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 240 people, planned
- Started
- 1 Sept 2025
- Expected to end
- 30 Apr 2030
- Type of study
- Observational, 2 groups
- Record updated
- 21 October 2026
Who can take part
- Age
- 0 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Any Participant with a molecularly confirmed diagnosis of mucopolysaccharidosis is eligible to enroll in this study
- Any healthy participant without a diagnosis of mucopolysaccharidosis whose age and biological sex can be matched with an enrolled mucopolysaccharidosis participant
- Parental / patient informed consent
Who cannot take part
- Any reason that the investigators would deem a patient not eligible to participate in this study
- Inability to participate in the assessments required for this study
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 99 years old?
Where in United States
- University of MinnesotaMinneapolis, United StatesContact: Donald Dengel, PhDNot yet recruiting
- Children's Hospital of Orange CountyOrange, United StatesContact: Nina MovsesyanTaking people
- Saint Louis UniversitySt Louis, United StatesContact: Adriana M Montano, PhDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to better understand how heart and blood vessel problems develop in people with Mucopolysaccharidosis (MPS). The investigators are looking at certain substances in the body called GAGs and proteoglycans to see how they affect the heart. The investigators also want to find reliable blood and urine markers that can help us track heart health and guide future treatments.
Read full original descriptionShow less
This study aims to answer two main questions:
1. Do people with MPS show faster changes in their blood vessels over time (such as thickening or stiffening of the carotid artery) compared to people without MPS? 2. Do people with MPS have higher levels of certain proteins in their blood (such as clusterin and inflammatory markers) that are linked to blood vessel changes?
What participants will do?
Participants will complete the following tests once a year for 4 years:
* Carotid ultrasound: an imaging test that looks at the blood vessels in the neck. * Echocardiogram: an ultrasound of the heart. * Blood draw * Urine collection
These tests help the investigators track changes in heart and blood vessel health over time.
The 2 groups in the trial
- MPS
Participants diagnosed with MPS I or MPS IVA
- Control
Participants who do not have an MPS diagnosis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Cardiovascular Structure and Function in Mucopolysaccharidosis Types I and IVA
- Criteria questions
- Built from NCT07361536, who can take part
- Record updated
- 21 October 2026